Circ re proposed change to Investment Policy

The Biotech Growth Trust PLC (the "Company")                  

                            Publication of circular                            

The Company has today published a circular (the "Circular") to Shareholders
seeking approval for a change to its Investment Policy.

The Directors, as advised by the Company's AIFM and Portfolio Manager, are
proposing that the Company's borrowing limit be increased from 15 per cent. to
20 per cent. of the Company's net assets. The Directors believe that this
amendment would be beneficial to Shareholders as it would provide an increased
level of flexibility to the Company to participate in compelling investment
opportunities as they arise. The Company's approach to using borrowing will not
change in practice and the level of borrowing adopted will continue to be
reviewed and agreed with the Directors and the Company's AIFM from time to
time, subject always to the proposed overall limit of 20 per cent. of the
Company's net assets.

Under the Listing Rules, the Company is required to seek the approval of
Shareholders for any material change to its Investment Policy. Therefore, an
ordinary resolution to approve the changes to the Investment Policy will be
proposed at a General Meeting, to be held at 10.00 a.m. on Tuesday, 31 March
2015.

Terms used and not defined in this announcement shall have the meanings given
in the circular dated 6 March 2015.

The circular will shortly be available for inspection at
www.morningstar.co.uk/uk/NSM and on the Company's website www.biotechgt.com

6 March 2015


For further information:

Victoria Hale
Company Secretary
Frostrow Capital LLP .........................020 3170 8732

Neil Morgan
Winterflood Investment Trusts ............... 020 3100 0292